Key result
Ischemic preconditioning reduced myocardial infarct size in both non-diabetic and type 2 diabetic rats irrespective of the duration of diabetes.
Why the study?
Does ischemic preconditioning reduce infarct size in a rat model of pre-, early, and late-stage type 2 diabetes mellitus?
Does ischemic preconditioning reduce infarct size in a rat model of pre-, early, and late-stage type 2 diabetes mellitus?
Ischemic preconditioning preserves its cardioprotective effect against ischemia-reperfusion injury regardless of the duration of type 2 diabetes in a rat model.
Answers are grounded in this paper and cite their sources.
IPC efficacy preserved across T2DM durations despite varying IR sensitivity; leaves open translation to human preconditioning strategies.
Augmented mortality and morbidity following an acute myocardial infarction in patients with diabetes mellitus Type 2 (T2DM) may be caused by increased sensitivity to ischemia reperfusion (IR) injury or altered activation of endogenous cardioprotective pathways modified by T2DM per se or ischemic preconditioning (IPC). We aimed to investigate, whether the duration of T2DM influences sensitivity against IR injury and the efficacy of IPC, and how myocardial glucose oxidation rate was involved. Male Zucker diabetic fatty rats (homozygote (fa/fa)) at ages 6-(prediabetic), 12- (onset diabetes) and 24-weeks of age (late diabetes) and their age-matched non-diabetic controls (heterozygote (fa/+) were subjected to IR injury in the Langendorff model and randomised to IPC stimulus or control. T2DM rats were endogenously protected at onset of diabetes, as infarct size was lower in 12-weeks T2DM animals than in 6- (35±2% vs 53±4%; P = 0.006) and 24-weeks animals (35±2% vs 72±4%; P<0.0001). IPC reduced infarct size in all groups irrespective of the presence of T2DM and its duration (32±3%; 20±2%; 36±4% respectively; (ANOVA P<0.0001). Compared to prediabetic rats, myocardial glucose oxidation rates were reduced during stabilisation and early reperfusion at onset of T2DM, but these animals retained the ability to increase oxidation rate in late reperfusion. Late diabetic rats had low glucose oxidation rates throughout stabilisation and reperfusion. Despite inherent differences in sensitivity to IR injury, the cardioprotective effect of IPC was preserved in our animal model of pre-, early and late stage T2DM and associated with adaptations to myocardial glucose oxidation capacity.
No takes yet. Share an insight, caveat, or question.
Hjortbak et al. (2018) studied Type 2 Diabetes Mellitus and Myocardial Ischemia Reperfusion Injury (n=112). Ischemic preconditioning vs. No ischemic preconditioning (control) was evaluated on Infarct size (p=<0.0001). Ischemic preconditioning reduced myocardial infarct size in both non-diabetic and type 2 diabetic rats irrespective of the duration of diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: